44 results about "Aqueous flow" patented technology

Methods and systems are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for reducing elevated intraocular pressure. Some embodiments described apparatus and methods useful in photoablation of tissues. In some embodiments, a photoablation apparatus is used to perforate a tissue, forming an aperture into a space behind the tissue. Gases formed during a photoablation process can be used to pressurize the space behind the tissue to enhance patency of the space. In some embodiments the tissue is the trabecular meshwork of the eye and a wall of Schlemm's canal, and the space behind the tissue is a portion of the lumen of Schlemm's canal. In some embodiments, the method is useful in the treatment of glaucoma by improving outflow from the anterior chamber of the eye into Schlemm's canal, reducing intraocular pressure.

A method and delivery system are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for reducing elevated intraocular pressure. Pulsed laser radiation is delivered from the distal end of a fiber-optic probe sufficient to cause photoablation of selected portions of the trabecular meshwork, the juxtacanalicular trabecular meshwork and an inner wall of Schlemm's canal in the target site. The fiber-optic probe may be advanced so as to create an aperture in the inner wall of Schlemm's canal in which fluid from the anterior chamber of the eye flows. The method and delivery system may further be used on any tissue types in the body.

A glaucoma drainage device has a tube shunting the anterior chamber to a drainage location. A power generator has a rotor coupled to a micro-generator. The power generator is configured to generate energy from aqueous flowing through the tube. The force required to drive the rotor can be controlled to control the flow of aqueous through the tube. Alternatively, energy generated by the power generator is stored in a power source that powers an active valve, a pressure sensor, or telemetry.

Methods and systems are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for reducing elevated intraocular pressure. Some embodiments described apparatus and methods useful in photoablation of tissues. In some embodiments, a photoablation apparatus is used to perforate a tissue, forming an aperture into a space behind the tissue. Gases formed during a photoablation process can be used to pressurize the space behind the tissue to enhance patency of the space. In some embodiments the tissue is the trabecular meshwork of the eye and a wall of Schlemm's canal, and the space behind the tissue is a portion of the lumen of Schlemm's canal. In some embodiments, the method is useful in the treatment of glaucoma by improving outflow from the anterior chamber of the eye into Schlemm's canal, reducing intraocular pressure.

A method and delivery system are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for reducing elevated intraocular pressure. Pulsed laser radiation is delivered from the distal end of a fiber-optic probe sufficient to cause photoablation of selected portions of the trabecular meshwork, the juxtacanalicular trabecular meshwork and an inner wall of Schlemm's canal in the target site. The fiber-optic probe may be advanced so as to create an aperture in the inner wall of Schlemm's canal in which fluid from the anterior chamber of the eye flows. The method and delivery system may further be used on any tissue types in the body.

Embodiments of the present invention provide a method and system of treating intraocular pressure. Laser light is directed to the ciliary region of the target eye. The light stimulates the ciliary region and ablates debris lodged therein. An immune response may be triggered by the stimulation of the ciliary body. Intraocular pressure is reduced by the increase in aqueous flow from the anterior chamber in the eye permitted by the resultant removal of debris blocking the uveo-scleral outflow pathway.

A posterior chamber phakic lens made from an elastomeric, foldable, highly biocompatible and permeable material. The lens has a generally circular optic and a plurality of integrally formed, filament-like haptics. The haptics project posteriorly from the optic and contain a raised feature or ridge that is sandwiched between the posterior iris and the zonules when implanted in an eye. Such a construction has a low vaulting force under compression, is size insensitive, provides for a stable lens once implanted in the eye, helps to avoid pupillary blockage and allows for improved aqueous flow around the natural lens.

A method and delivery system are disclosed for creating an aqueous flow pathway in the trabecular meshwork, juxtacanalicular trabecular meshwork and Schlemm's canal of an eye for reducing elevated intraocular pressure. Pulsed laser radiation is delivered from the distal end of a fiber-optic probe sufficient to cause photoablation of selected portions of the trabecular meshwork, the juxtacanalicular trabecular meshwork and an inner wall of Schlemm's canal in the target site. The fiber-optic probe may be advanced so as to create an aperture in the inner wall of Schlemm's canal in which fluid from the anterior chamber of the eye flows. The method and delivery system may further be used on any tissue types in the body.

A non-aqueous flow cell energy storage device comprises a ionically conductive separator, which separator comprises a polyurethane prepared by curing an isocyanate capped prepolymer, which prepolymer was prepared from a polyol having polycarbonate backbone, wherein the separator may be impregnated with electrolyte salts and / or swelled by an organic solvent.

Sequences and protocols for treatment of eye conditions by use of RNA interference are disclosed. Target genes are selected from those responsible for aqueous flow or aqueous outflow, while particularly preferred conditions to be treated include glaucoma and uveitis.

A treatment process for an aqueous phase which contains oil droplets, possibly of 10-50 nm diameter, in aqueous flow from a hydrocyclone separator, comprises bringing the water into contact with a surface subdivided into areas of differing surface energy and affinity for oil and such that when the surface is submerged in an aqueous phase, oil droplets adhere to it with an apparent contact angle in a range from 90 to 150 degrees. Areas of the surface may reduce their affinity for oil in response to an external stimulus causing controlled release of droplets adhering to the surface. The process may be used to remove oil droplets from water produced by an oil or gas well, after downhole oil water separation or after production at a at a well head, or used to coalesce droplets in such water to a larger size to enable conventional separation.

A battery system comprising a sealed aqueous flow battery that employs a passive, in-tank electrolyte recombination system. The recombination system allows for electrolyte stabilization in batteries where hydrogen evolution may occur as a side reaction without the need to use any externally-supplied rebalancing reactants. The system is a passive system that does not require a control system, additional pumps, or pumping energy.

Non-aqueous liquid compositions comprising nimodipine having improved stability over aqueous compositions comprising nimodipine are provided herein. Methods of improving neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms with the non-aqueous liquid compositions of the present invention are also detailed herein.

Sequences and protocols for treatment of eye conditions by use of RNA interference are disclosed. Target genes are selected from those responsible for aqueous flow or aqueous outflow, while particularly preferred conditions to be treated include glaucoma and uveitis.

A posterior chamber phakic lens made from an elastomeric, foldable, highly biocompatible and permeable material. The lens has a generally circular optic and a plurality of integrally formed, filament-like haptics. The haptics project posteriorly from the optic and contain a raised feature or ridge that is sandwiched between the posterior iris and the zonules when implanted in an eye. Such a construction has a low vaulting force under compression, is size insensitive, provides for a stable lens once implanted in the eye, helps to avoid pupillary blockage and allows for improved aqueous flow around the natural lens.

The invention provides an aqueous organic flow battery electrolyte. The aqueous organic flow battery electrolyte is composed of an electrolyte compound and a supporting electrolyte solution. The electrolyte compound is composed of an organic electrolyte and a coating material for coating the organic electrolyte. The coating material is an annular molecule with a hydrophilic outer edge, a hydrophobic inner cavity and a cavity. The organic electrolyte is an electrolyte poor in water solubility on its own or a product poor in water solubility after gaining and losing electrons. The invention alsoprovides a preparation method of the aqueous organic flow battery electrolyte. The invention also provides an aqueous organic flow battery. The electrolyte provided by the invention can replace the modification step of the organic electrolyte. The organic electrolyte poor in water solubility is directly applied to the aqueous flow battery, so that the cost of the flow battery is reduced.

An aqueous liquid composition comprising: (a) 2-amino-3-(4-bromobenzoyl)phenylacetic acid or its pharmacologically acceptable salt or hydrate; (b) a non-ionic surfactant; and (c) a preservative; wherein at least 90 percent of the original amount of said 2-amino-3-(4-bromobenzoyl)phenylacetic acid or pharmacologically acceptable salt or hydrate remains in the composition after storage at 60° C., for 4 weeks. The composition can satisfy the preservative efficacy of US Pharmacopeia 35 (2012). The composition is useful for the treatment of ocular or nasal inflammation of diverse etiology.

Disclosed is an aqueous liquid preparation comprising (A) gatifloxacin, a pharmacologically acceptable salt thereof or a hydrate gatifloxacin or the salt, (B) hyaluronic acid or a pharmacologically acceptable salt thereof, and (C) a polyhydric alcohol. The aqueous liquid preparation is an ophthalmic aqueous liquid preparation excellent in the retention of gatifloxacin in a tear fluid and the penetration of gatifloxacin into an aqueous humor and a conjunctiva.

An improved posterior chamber phakic intraocular lens (PCP-IOL) having a haptic with a collar, self-adjusting struts, and lens is disclosed. Haptic or lens of the PCP-IOL may include a protected orifice. A disclosed PCP-IOL may be configured to fit anatomy of varying sizes, and may be self-centering; additionally, a PCP-IOL as set forth herein may allow peripheral aqueous flow between anterior and posterior chambers of a patient's eye.

The invention relates to an apparatus for the filtration of aqueous liquid that is capable of effectively removing suspended particles from aqueous liquid during a prolonged period of time without clogging of the particulate filter media and associated pressure build-up. This filtration apparatus comprises: ⋅a filtration chamber comprising an inlet opening that is located near the bottom of the filtration chamber, and an outlet opening that is located near the top of the filtration chamber; ⋅a screen covering the outlet opening of the filtration chamber; ⋅a first dosing unit that is located upstream of the filtration chamber adapted to release water-soluble components into the stream of aqueous liquid that flows from the inlet to the filtration chamber; ⋅a particulate filter media that partially fills the interior of the filtration chamber; ⋅a flow regulator that regulates the flow rate of aqueous liquid through the filtration chamber and that can operate in a high flow rate mode or a reduced flow rate mode; ⋅a timer that controls the flow regulator; wherein the timer is programmed to alternatingly switch the flow regulator from the high flow rate mode to the reduced flow rate mode.

A liquid additive feed system for a pressure controlled fluid flow line, which may include a liquid reservoir, a manifold, a flow line pressure regulation module, a flow controlled inlet line, a flow controlled feed line, and a diffusion interface, which dynamically adjustably delivers a metered dosage of liquid additive into a controlled aqueous flow delivery system.

An improved posterior chamber phakic intraocular lens (PCP-IOL) having a haptic with a collar, self-adjusting struts, and lens is disclosed. Haptic or lens of the PCP-IOL may include a protected orifice. A disclosed PCP-IOL may be configured to fit anatomy of varying sizes, and may be self-centering; additionally, a PCP-IOL as set forth herein may allow peripheral aqueous flow between anterior and posterior chambers of a patient's eye.

The invention discloses a method for preparing an MAS (MgO-Al2O3-SiO2) series microcrystal glass electronic substrate in a water-based tape-casting mode, and relates to a method for preparing the MAS series microcrystal glass electronic substrate, and the method can be used for solving the problems that the use of organic solvents can do harm to human bodies and the environment, the production process has potential safety hazard, the production cost is relatively high and reception of signals is slow in the data transmission process in a conventional method for preparing the MAS series microcrystal glass electronic substrate. The method comprises the following steps: I, preparing MAS series glass powder, II, preparing MAS water-based slurry, III, preparing a crude glass strip, IV, preparing a crude substrate material blank, and V, sintering. By adopting the method, harm to the human bodies and the environment is alleviated, the potential safety hazard in the production process is reduced, the cost is low, and the problem that the reception of the signals is slow in the data transmission process is solved. The method is applied to preparation of the MAS series microcrystal glass electronic substrate.

A method for separating a salified phenolic compound from a reaction medium including same is described. Also described, is a method for separating salified phenolic compounds from an aqueous reaction medium resulting from the reaction of a phenolic compound and glyoxylic acid in the presence of a base, which leads to a reaction medium including at least the excess of the starting salified phenolic compound and the various salified mandelic compounds resulting from the reaction, wherein the reaction medium including the starting salified phenolic compound is contacted with an adsorbent substrate. This leads to the selective adsorption of the phenolic compound onto said substrate and to the recovery of an aqueous flow containing the salified mandelic compounds from the reaction, and in that the phenolic compound attached onto the adsorbent is desorbed by means of a regenerating treatment of the adsorbent.

The invention discloses a fast heat-exchanging water storage tank, which comprises a tank body. The tank body includes an outer shell, a middle insulation layer and an inner tank. The middle insulation layer is between the outer shell and the inner tank. It is coiled and fixed in the liner. The water inlet end of the water and liquid flat tube protrudes from the upper top surface of the box. The horizontal circulation flat tube is serpentine and coiled so it is fixed in the inner tank. The horizontal circulation flat tube and the water and liquid flat tube Inserted together, the side wall of the horizontal flow flat tube is attached to the side wall of the water liquid flat tube, one end of the horizontal flow flat tube extends out of the front side wall of the box, and the other end sticks out of the back side wall of the box. A water outlet pipe is fixed at the bottom of the box body, and the water outlet pipe communicates with the inner cavity of the box body. It has the effect of storing water liquid, its structure is simple, and its heat exchange effect is good and heat exchange is fast.

The invention belongs to the technical field of cosmetics, and discloses an aqueous liquid eye shadow and a preparation method thereof. The aqueous liquid eye shadow comprises a thickening agent, and the thickening agent comprises carbomer, polyacrylate-13, polyisobutene and polysorbate-20. According to the aqueous liquid eye shadow, carbomer, polyacrylate-13, polyisobutene and polysorbate-20 are compounded to serve as the thickening agent, so that the aqueous liquid eye shadow has proper viscosity, the viscosity at normal temperature is about 1250 cp, and the aqueous liquid eye shadow is fresh and not sticky after being used and has excellent skin feeling after being used; and the thickening agent can well disperse and suspend pearl powder, and meanwhile, in the production process, a material body has proper viscosity, few bubbles, high flowability and easiness in filling.

A solution for imaging an eye of a patient is described. An illumination device can illuminate a linear volume of aqueous fluid of the eye of the patient with visible and / or infrared light from a location in a range between 25 to 65 degrees from a line of sight of the eye. At least one imaging device can acquire image data of the eye while it is being illuminated by the illumination device. The image data can be evaluated to determine one or more attributes of an aqueous fluid in an anterior segment of the eye delimited by the posterior surface of the cornea and the most anterior surfaces of the iris or lens and / or one or more attributes of the iris, eye, or surrounding tissues.